Evertt Laboratories Acquires Quinnova Pharmaceuticals

December 19, 2013
Melanie Sena

Melanie Sena is community editor of Pharmaceutical Technology.

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Everett Laboratories, a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquarted in Madrid, Spain, has acquired Quinnova Pharmaceuticals, from parent company Amneal Enterprises.

The acquisition will result in the strategic expansion of Everett into the US dermatology market.

Summary: Everett Laboratories